Identification and characterization of lipopolysaccharide binding protein (LBP) as an estrogen receptor α specific serum biomarker

References

• Ariazi EA, Ariazi JL, Cordera F, Jordan VC. (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:181–202.
   PubMed Web of Science ®Google Scholar
• Brown CM, Mulcahey TA, Filipek NC, Wise PM. (2010). Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 151:4916–4925.
   PubMed Web of Science ®Google Scholar
• Carpenter KD, Korach KS. (2006). Potential biological functions emerging from the different estrogen receptors. Ann N Y Acad Sci 1092:361–373.
   PubMed Web of Science ®Google Scholar
• Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS. (1995). Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 9:1441–1454.
   PubMed Web of Science ®Google Scholar
• Couse JF, Korach KS. (1999). Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358–417.
   PubMed Web of Science ®Google Scholar
• Cristofaro PA, Opal SM, Palardy JE, Parejo NA, Jhung J, Keith JC Jr, Harris HA. (2006). WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med 34:2188–2193.
   PubMed Web of Science ®Google Scholar
• Cunningham M, Gilkeson G. (2011). Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 40:66–73.
   PubMed Web of Science ®Google Scholar
• Curran EM, Berghaus LJ, Vernetti NJ, Saporita AJ, Lubahn DB, Estes DM. (2001). Natural killer cells express estrogen receptor-alpha and estrogen receptor-beta and can respond to estrogen via a non-estrogen receptor-alpha-mediated pathway. Cell Immunol 214:12–20.
   PubMed Web of Science ®Google Scholar
• Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC. (2008). Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J Immunol 180:630–636.
   PubMed Web of Science ®Google Scholar
• Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. (2000). Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127:4277–4291.
   PubMed Web of Science ®Google Scholar
• Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD. (1994). Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269–277.
   PubMed Web of Science ®Google Scholar
• Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC Jr (2003). Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144:4241–4249.
   PubMed Web of Science ®Google Scholar
• Hewitt SC, Harrell JC, Korach KS. (2005). Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67:285–308.
   PubMed Web of Science ®Google Scholar
• Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR, Kobayashi S, Davis C, Dai H, He YD, Stephaniants SB, Cavet G, Walker WL, West A, Coffey E, Shoemaker DD, Stoughton R, Blanchard AP, Friend SH, Linsley PS. (2001). Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19:342–347.
   PubMed Web of Science ®Google Scholar
• Ikejima K, Enomoto N, Iimuro Y, Ikejima A, Fang D, Xu J, Forman DT, Brenner DA, Thurman RG. (1998). Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 274:G669–G676.
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA. (2000). Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163–93; discussion 194.
   PubMedGoogle Scholar
• Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. (1998). Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95:15677–15682.
   PubMed Web of Science ®Google Scholar
• Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90:11162–11166.
   PubMed Web of Science ®Google Scholar
• Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE. (2003). Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 144:2055–2067.
   PubMed Web of Science ®Google Scholar
• Mueller SO, Korach KS. (2001). Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr Opin Pharmacol 1:613–619.
   PubMedGoogle Scholar
• Owens JW, Ashby J. (2002). Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit Rev Toxicol 32:445–520.
   PubMed Web of Science ®Google Scholar
• Pearce ST, Jordan VC. (2004). The biological role of estrogen receptors alpha and beta in cancer. Crit Rev Oncol Hematol 50:3–22.
   PubMed Web of Science ®Google Scholar
• Ramadori G, Meyer zum Buschenfelde KH, Tobias PS, Mathison JC, Ulevitch RJ. (1990). Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 58:89–94.
   PubMed Web of Science ®Google Scholar
• Rettew JA, Huet YM, Marriott I. (2009). Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology 150:3877–3884.
   PubMed Web of Science ®Google Scholar
• Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ. (2005). 17 β-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 179:637–643.
   PubMed Web of Science ®Google Scholar
• Schumann RR, Latz E. (2000). Lipopolysaccharide-binding protein. Chem Immunol 74:42–60.
   PubMed Web of Science ®Google Scholar
• Sheth P, Delos Santos N, Seth A, LaRusso NF, Rao RK. (2007). Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 293:G308–G318.
   PubMed Web of Science ®Google Scholar
• Skarnes RC. (1966). The inactivation of endotoxin after interaction with certain proteins of normal serum. Ann N Y Acad Sci 133:644–662.
   PubMed Web of Science ®Google Scholar
• Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE. (1999). Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 163:4168–4174.
   PubMed Web of Science ®Google Scholar
• Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. (2000). Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 43:4934–4947.
   PubMed Web of Science ®Google Scholar
• Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. (2002). Antagonists selective for estrogen receptor alpha. Endocrinology 143:941–947.
   PubMed Web of Science ®Google Scholar
• Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. (1995). Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 270:10482–10488.
   PubMed Web of Science ®Google Scholar
• Tobias PS, Ulevitch RJ. (1993). Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology 187:227–232.
   PubMed Web of Science ®Google Scholar
• Tu Z, Argmann C, Wong KK, Mitnaul LJ, Edwards S, Sach IC, Zhu J, Schadt EE. (2009). Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network. Genome Res 19:1057–1067.
   PubMed Web of Science ®Google Scholar
• Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A. (2003). Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA 100:9614–9619.
   PubMed Web of Science ®Google Scholar
• Vollmer T, Piper C, Kleesiek K, Dreier J. (2009). Lipopolysaccharide-binding protein: a new biomarker for infectious endocarditis? Clin Chem 55:295–304.
   PubMed Web of Science ®Google Scholar
• Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433.
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Hailman E, Wright SD. (1995). Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181:1743–1754.
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. (1994). Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180:1025–1035.
   PubMed Web of Science ®Google Scholar
• Wurfel MM, Monks BG, Ingalls RR, Dedrick RL, Delude R, Zhou D, Lamping N, Schumann RR, Thieringer R, Fenton MJ, Wright SD, Golenbock D. (1997). Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 186:2051–2056.
   PubMed Web of Science ®Google Scholar